Buy Crypto
Markets
Spot
FuturesANT
Earn
Event Center
Rewards Hub
More
100%+ PoR
MRKR

Marker Therapeutics, Inc. (MRKR)

NASDAQ
$1.10
-$0.21
(-15.91%)
Previous Close: ⁦$1.32⁩
Market Closed

Last updated: ⁦2026-11-22 06:11:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Marker Therapeutics, Inc. (MRKR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.10, with a market capitalization of $22.01M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.81 to $2.46. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$22.01M

$1.34

$1.42

$1.09

$1.32

1.83M

720.96K

--

$2.46

$0.81

--

2026-06-30

Marker Therapeutics, Inc. (MRKR) Latest Closing Stock Price

Marker Therapeutics, Inc. (MRKR) last closed at $1.10 as of 2026-11-21 01:00:00, down 15.91% ($0.21) from the previous close of $1.32.

During the latest regular trading session, MRKR traded between $1.09 and $1.42, with a volume of 1.83M shares. The closing price was near the lower end and near the lower end of its 52-week range.

Marker Therapeutics, Inc. (MRKR) 7-Day Stock Price Change

Over the past seven days, Marker Therapeutics, Inc. (MRKR) moved from $0.90 to $1.10, representing a gain of 22.67% ($0.20).

The stock traded between $0.81 and $1.68 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 5.53 million shares, up versus the previous seven-day period, indicating higher trading activity.

MRKR 52-Week Price Position

Position in Range: 17.8%

52W Low$0.81
52W High$2.46

MRKR is currently trading at $1.10, placing it 17.8% of the way from its 52-week low of $0.81 to its 52-week high of $2.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Marker Therapeutics, Inc. (MRKR)?

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Marker Therapeutics, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
5
Exchange
NASDAQ
Company Website

MRKR News

Latest news related to Marker Therapeutics, Inc. and MRKR stock.

  • Benzinga

    12 Health Care Stocks Moving In Thursday's Intraday Session

    Gainers VivoSim Labs (NASDAQ:VIVS) shares increased by 82.0% to $0.22 during Thursday's regular session. The market value of their outstanding shares is at $2.4 million. Marker Therapeutics (NASDAQ:MRKR) shares

    Read Full Article
  • Benzinga

    Marker Therapeutics Awarded $16.2M Product Development Research Grant From Cancer Prevention And Research Institute Of Texas

    Highly competitive grant award provides significant non-dilutive funding to support Phase 2 development of MT-601 in CAR-relapsed lymphomaCPRIT award builds on encouraging Phase 1 clinical results, with additional

    Read Full Article
  • Benzinga

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

    Gainers SciSparc (NASDAQ:SPRC) stock increased by 62.9% to $0.44 during Thursday's pre-market session. Pulmatrix (NASDAQ:PULM) stock rose 13.58% to $1.52. The company's market cap stands at $4.8 million. As

    Read Full Article
  • Benzinga

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

    Gainers Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out

    Read Full Article
  • Benzinga

    12 Health Care Stocks Moving In Friday's After-Market Session

    Gainers InflaRx (NASDAQ:IFRX) stock rose 12.7% to $1.32 during Friday's after-market session. The market value of their outstanding shares is at $182.6 million. Instinct Bio Technical Co (NASDAQ:BIOT) stock moved

    Read Full Article

Ways to Trade MRKR at MEXC

MRKR MEXC RealStocks

Own real MRKR shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Marker Therapeutics, Inc. (MRKR) Stock on MEXC

Eligible investors can buy real shares of Marker Therapeutics, Inc. (MRKR) through MEXC Stocks. Follow these three steps to open a Stocks account, transfer USDT, and place a Stocks order.

Step 1: Open and Verify Your Stocks Account
Step 1: Open and Verify Your Stocks Account
Log in to the MEXC App, go to Trade → Stocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your Stocks Account
Step 2: Transfer USDT to Your Stocks Account
Go to Wallets → Stocks and transfer USDT from your Spot Account to your Stocks Account. Stocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for MRKR and Place Your Order
Step 3: Search for MRKR and Place Your Order
Open the Stocks trading page and search for MRKR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your Stocks Account.

Frequently Asked Questions (FAQ)

1.What is Marker Therapeutics, Inc. (MRKR) stock price today?
Marker Therapeutics, Inc. (MRKR) is currently trading at $1.10, down 15.91% ($0.21) from the previous close of $1.32. Intraday prices update in real time during regular trading hours.
2.Is MRKR stock going up or down today?
As of 2026-11-21 01:00:00, MRKR is trading at $1.10, down 15.91% ($0.21) from its previous close of $1.32. The stock has traded between $1.09 and $1.42 during today’s regular session. Past price movements do not guarantee future results.
3.What is MRKR pre-market price?
As of 2026-11-21 01:00:00, MRKR is trading at $1.37 in pre-market trading, up 3.41% ($0.04) from the previous close of $1.32. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is MRKR after-hours price?
As of 2026-11-21 01:00:00, MRKR is trading at $1.03 in after-hours trading, down 7.16% ($0.08) from the regular-session close of $1.10. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is MRKR stock trading now?
MRKR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does MRKR sit relative to its 52-week high and low?
Over the past 52 weeks, MRKR has traded between a low of $0.81 and a high of $2.46. At $1.10, the stock is positioned 17.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Marker Therapeutics, Inc. in?
Marker Therapeutics, Inc. (MRKR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Marker Therapeutics, Inc.'s market capitalization and where is it listed?
Marker Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $22.01M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is MRKR valued in terms of P/E ratio and EPS?
MRKR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.51. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Marker Therapeutics, Inc. pay a dividend?
Marker Therapeutics, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More Stocks

Largest Market Cap

See stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MRKR, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

MRKR Stock Calculator

Estimate the value between MRKR shares and USD.

MRKR Shares to USD

MRKR Shares
MRKR
MRKR
USD
USD
USD

1.00 MRKR shares = 1.104 USD

Calculations are estimates based on the latest available price and are for reference only.